Acadia Healthcare Company, Inc.
ACHCHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeAcadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. With a market capitalization of $2.56B, it sits in mid-cap territory. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Market Cap
$2.56B
Beta
0.62
P/E (TTM)
—
P/E (Fwd)
15.09
EPS (TTM)
$-12.43
EPS (Fwd)
$1.82
ROE
-41.4%
ROA
3.6%
Cash
$171.3M
Total Debt
$2.59B
Free CF
-$105.0M
52W Change
33.6%
Annual Financials
Cash vs Debt
Where ACHC stands vs its 150-day and 200-day moving averages
As of the September 2, 2026 close, ACHC finished 10.78% above its 150-day moving average ($25.50) and 24.12% above its 200-day moving average ($22.76). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ACHC overbought or oversold?
At the September 2, 2026 close, ACHC's RSI(14) was 37.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ACHC has $171.3M in cash with $2.59B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$105.0M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -41.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.61B (2022) to $3.31B (2025), reflecting a 27% increase over the period.
With a beta below 0.7, Acadia Healthcare Company, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Acadia Healthcare Company, Inc.'s trajectory.